The 32-month evaluation panel
- Sample
- Treatment n=226, clean control n=55 (pilot evaluation cohort, baseline January 2022)
- Design
- Recruit-and-delay RCT, became quasi-experimental through capacity-driven crossovers; baseline-adjusted estimates
- Time horizon
- 32 months
- Partners
- University of Paderborn (Schneider, Herdejürgen, Islam, Kabst); independent partial replication by Jamie Walsh, The Agency Fund
- Status
- Findings published in Kabakoo's April 2026 evidence brief.
- Link
- Evidence brief PDF and replication package via research@kabakoo.africa
What it found
| Outcome | Result | Source |
|---|---|---|
| Share earning ≤40,000 FCFA/month | 46% (control) vs 38% (treatment) | 32-month panel | July 2026 analysis round |
| Share earning >250,000 FCFA/month | 7% (control) vs 11% (treatment) | 32-month panel | July 2026 analysis round |
| Growth mindset | +0.14 to +0.25 SD | 32-month panel | University of Paderborn evaluation | April 2026 |
| Continued skills training | +0.36 SD (p=0.004) | 32-month panel | University of Paderborn evaluation | April 2026 |
| Earnings as an employee | +0.25 SD (p=0.029) | 32-month panel | University of Paderborn evaluation | April 2026 |
| Made no professional investment | 5% of treated vs 14% of clean controls (p=0.005) | 32-month panel | University of Paderborn evaluation | April 2026 |
| Kabakoo Behavioral Index | +0.33 behaviors on a 0–6 scale (p=0.077) | 32-month panel | University of Paderborn evaluation | April 2026 |
| Net Promoter Score | 61 → 77 | First survey vs 32-month follow-up, n=358/150 | April 2026 |